| Praveen Reddy Elmati, | |
|
18229 Dupont Blvd, Georgetown, DE 19947-3127 | |
| (302) 514-7246 | |
| Not Available |
| Full Name | Praveen Reddy Elmati |
|---|---|
| Gender | Male |
| Speciality | Pain Medicine - Interventional Pain Medicine |
| Location | 18229 Dupont Blvd, Georgetown, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427544105 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | C1-0025796 (Delaware) | Primary |
| Entity Name | Sussex Pain Relief Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578886180 PECOS PAC ID: 8325171887 Enrollment ID: O20100804000421 |
News Archive
The development of safe and effective HIV prevention methods for cisgender women has long been a global health priority, yet research in women during pregnancy and breastfeeding, when they are most vulnerable to infection, has lagged years behind.
The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass. The use of a GLP1 challenge could thus function as a novel predictive biomarker for personalized treatment of type 2 diabetes and obesity.
Scientists from the University of New South Wales, Sydney, have found that a simple nasal spray may help people deal with irrational fears.
University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
Seattle Genetics, Inc. today announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Praveen Reddy Elmati, 18229 Dupont Blvd, Georgetown, DE 19947-3127 Ph: (302) 514-7246 | Praveen Reddy Elmati, 18229 Dupont Blvd, Georgetown, DE 19947-3127 Ph: (302) 514-7246 |
News Archive
The development of safe and effective HIV prevention methods for cisgender women has long been a global health priority, yet research in women during pregnancy and breastfeeding, when they are most vulnerable to infection, has lagged years behind.
The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass. The use of a GLP1 challenge could thus function as a novel predictive biomarker for personalized treatment of type 2 diabetes and obesity.
Scientists from the University of New South Wales, Sydney, have found that a simple nasal spray may help people deal with irrational fears.
University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.
Seattle Genetics, Inc. today announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas.
› Verified 9 days ago